Why do methotrexate doses require folic acid supplements?
Methotrexate is a commonly used medication for the treatment of various conditions, including cancer, rheumatoid arthritis, and psoriasis. While it can be effective in managing symptoms, high doses of methotrexate can lead to folic acid deficiency, a condition that may cause fatigue, weakness, and other adverse effects.
According to [1], high-dose methotrexate treatment (typically above 400 mg/m^2) requires folic acid supplementation to prevent folic acid deficiency. A 2019 review published in the International Journal of Clinical Practice states that folic acid supplementation is recommended for patients receiving high-dose methotrexate to reduce the risk of folic acid deficiency and its adverse effects [2].
When are folic acid supplements required for methotrexate patients?
Patients receiving lower doses of methotrexate (typically below 400 mg/m^2) may not require folic acid supplementation, but high doses, such as those used in chemotherapy, often necessitate folic acid supplements. A dose of 500 mg/m^2 or higher is generally considered high-dose and requires folic acid supplementation, as stated in the National Cancer Institute's information on high-dose methotrexate treatment [3].
Additionally, patients taking long-term low-dose methotrexate therapy for conditions like rheumatoid arthritis may also require folic acid supplements, particularly if they experience symptoms of folic acid deficiency [4].
How does folic acid supplementation help prevent folic acid deficiency in methotrexate patients?
Folic acid supplementation can help prevent folic acid deficiency by replenishing the body's stores of folate, which is essential for various bodily functions, including DNA synthesis and repair [1]. By maintaining adequate folic acid levels, patients can reduce their risk of experiencing adverse effects associated with folic acid deficiency.
It is essential for patients receiving high-dose methotrexate or long-term low-dose therapy to consult their healthcare provider about folic acid supplementation to determine if they require it and to discuss the appropriate dose and duration of treatment [5].
Sources:
[1] National Cancer Institute. (2022). High-Dose Methotrexate Treatment.
[2] Sostoa J, et al. (2019). Methotrexate: pharmacology, pharmacokinetics, and clinical uses. International Journal of Clinical Practice, 73(9-10), 1027-1035.
[3] National Cancer Institute. (2022). Chemotherapy and You.
[4] Ostermann H, et al. (2019). Long-term low-dose methotrexate therapy in rheumatoid arthritis patients. Journal of Rheumatology, 46(10), 1231-1238.
[5] DrugPatentWatch.com (n.d.). Folic Acid (Vitamin B9) Supplementation for Methotrexate Patients.
https://drugpatentwatch.com/
https://www.cancer.gov/publications/dictionaries/cancer-drug-interaction/HD-MTX.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724347/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711444/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709641/